Predicting progression from mild cognitive impairment to Alzheimer's disease using longitudinal callosal atrophy

Sang Han Lee1, Alvin H Bachman1, Donghyeon Yu2

  • 1Center for Biomedical Imaging and Neuromodulation, The Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA.

Abstract

Insights

Annual callosal atrophy, a measure of brain structure change, can predict the conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD), particularly in females.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biomedical Engineering

Background:

  • Mild cognitive impairment (MCI) is a prodromal stage for Alzheimer's disease (AD).
  • Identifying predictors of MCI-to-AD conversion is crucial for early intervention.

Purpose of the Study:

  • To investigate if longitudinal changes in corpus callosum thickness can predict conversion from MCI to AD.
  • To explore potential sex differences in the predictive accuracy and relevant brain regions.

Main Methods:

  • Utilized longitudinal MRI scans from 132 MCI subjects (Alzheimer's Disease Neuroimaging Initiative).
  • Calculated annual changes in corpus callosum thickness profile.
  • Employed a logistic regression model with fused lasso regularization for prediction.

Main Results:

  • Achieved an 84% prediction accuracy in females and 61% in males.
  • Identified distinct predictive regions of the corpus callosum between sexes.
  • Female prediction involved the genu, rostrum, and posterior body; male prediction involved the genu and splenium.

Conclusions:

  • Longitudinal callosal atrophy is a significant predictor of MCI-to-AD conversion.
  • Prediction accuracy is notably higher in females compared to males.
  • Sex-specific patterns of callosal atrophy influence conversion prediction.